Insider trades
Steve Pakola, Chief Officer of Regenxbio RGNX, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $221.7K. The latest trade was on 05/11.
Steve Pakola
Chief Medical Officer
- Company
- Regenxbio RGNX
- First filing
- 23/01/05
- Trades
- 22 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$221.7K
- Last trade
- 05/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RegenxbioRGNX | Open-market sale10b5-1 plan | 05/11 | 05/13 | 15,309 sh | $11.02 | $168,705.18 | −6.2% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 03/10 | 03/12 | 5,124 sh | $10.35 | $53,033.4 | −2.0% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 24/03/05 | 24/03/07 | 12,878 sh | $28.36 | $365,220.08 | −10.7% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 24/01/03 | 24/01/04 | 17,237 sh | $17.39 | $299,751.43 | −13.9% |
RegenxbioRGNX | Open-market sale | 23/01/03 | 23/01/05 | 3,138 sh | $22.17 | $69,569.46 | −20.5% |